These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 22186334)

  • 1. Development of a novel ketoprofen transdermal patch: effect of almond oil as penetration enhancers on in-vitro and ex-vivo penetration of ketoprofen through rabbit skin.
    Hussain A; Khan GM; Shah SU; Shah KU; Rahim N; Wahab A; Rehman AU
    Pak J Pharm Sci; 2012 Jan; 25(1):227-32. PubMed ID: 22186334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of olive oil on transdermal penetration of flurbiprofen from topical gel as enhancer.
    Hussain A; Khan GM; Jan SU; Shah S; Shah K; Akhlaq M; Rahim N; Nawaz A; Wahab A
    Pak J Pharm Sci; 2012 Apr; 25(2):365-9. PubMed ID: 22459463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and in vitro evaluation of clotrimazole gel containing almond oil and tween 80 as penetration enhancer for topical application.
    Nawaz A; Jan SU; Khan NR; Hussain A; Khan GM
    Pak J Pharm Sci; 2013 May; 26(3):617-22. PubMed ID: 23625439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced transdermal delivery of ketoprofen from bioadhesive gels.
    Singh S; Gajra B; Rawat M; Muthu MS
    Pak J Pharm Sci; 2009 Apr; 22(2):193-8. PubMed ID: 19339232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative in vitro and in vivo studies on the permeation and penetration of ketoprofen and ibuprofen in human skin].
    Bock U; Krause W; Otto J; Haltner E
    Arzneimittelforschung; 2004; 54(9):522-9. PubMed ID: 15500198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation, and physical, in vitro and ex vivo evaluation of transdermal ibuprofen hydrogels containing turpentine oil as penetration enhancer.
    Khan NR; Khan GM; Wahab A; Khan AR; Hussain A; Nawaz A; Akhlaq M
    Pharmazie; 2011 Nov; 66(11):849-52. PubMed ID: 22204130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of permeation enhancers on the release of ketoprofen through transdermal drug delivery systems.
    Singh SK; Durrani MJ; Reddy IK; Khan MA
    Pharmazie; 1996 Oct; 51(10):741-4. PubMed ID: 8941942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation development, in vitro and in vivo evaluation of microemulsion-based gel loaded with ketoprofen.
    Nikumbh KV; Sevankar SG; Patil MP
    Drug Deliv; 2015; 22(4):509-15. PubMed ID: 24266589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microdialysis assessment of percutaneous penetration of ketoprofen after transdermal administration to hairless rats and domestic pigs.
    Shinkai N; Korenaga K; Okumura Y; Mizu H; Yamauchi H
    Eur J Pharm Biopharm; 2011 Aug; 78(3):415-21. PubMed ID: 21397690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical characteristics, pharmacological properties and clinical efficacy of the ketoprofen patch: a new patch formulation.
    Adachi H; Ioppolo F; Paoloni M; Santilli V
    Eur Rev Med Pharmacol Sci; 2011 Jul; 15(7):823-30. PubMed ID: 21780552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of microneedle on the pharmacokinetics of ketoprofen from its transdermal formulations.
    So JW; Park HH; Lee SS; Kim DC; Shin SC; Cho CW
    Drug Deliv; 2009 Jan; 16(1):52-6. PubMed ID: 19555309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and evaluation of once-a-day transdermal gels of diclofenac diethylamine.
    Baboota S; Shakeel F; Kohli K
    Methods Find Exp Clin Pharmacol; 2006 Mar; 28(2):109-14. PubMed ID: 16636721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal enhancement strategy of ketoprofen and teriflunomide: The effect of enhanced drug-drug intermolecular interaction by permeation enhancer on drug release of compound transdermal patch.
    Liu C; Guan Y; Tian Q; Shi X; Fang L
    Int J Pharm; 2019 Dec; 572():118800. PubMed ID: 31678378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of percutaneous permeation of flurbiprofen and ketoprofen after application of transdermal patches using a lateral sectioning approach in hairless rats.
    Goi N; Morishita K; Taniguchi A; Ishii T; Saitoh K
    Pharm Dev Technol; 2010 Dec; 15(6):658-65. PubMed ID: 20883157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterisation of novel analgesic product based on self-regulating drug carriers.
    Cevc G; Vierl U; Mazgareanu S
    Int J Pharm; 2008 Aug; 360(1-2):18-28. PubMed ID: 18524509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-articular penetration of ketoprofen and analgesic effects after topical patch application in rats.
    Shinkai N; Korenaga K; Mizu H; Yamauchi H
    J Control Release; 2008 Oct; 131(2):107-12. PubMed ID: 18680771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular State of Active Pharmaceutical Ingredients in Ketoprofen Dermal Patches Characterized by Pharmaceutical Evaluation.
    Azuma M; Fujii M; Inoue M; Hisada H; Koide T; Kemper M; Yamamoto Y; Suzuki N; Suzuki T; Fukami T
    Biol Pharm Bull; 2018; 41(9):1348-1354. PubMed ID: 30175772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cremophor RH40-PEG 400 microemulsions as transdermal drug delivery carrier for ketoprofen.
    Ngawhirunpat T; Worachun N; Opanasopit P; Rojanarata T; Panomsuk S
    Pharm Dev Technol; 2013; 18(4):798-803. PubMed ID: 22023398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel biomaterial for transdermal application: in vitro and in vivo characterization.
    Mundada AS; Avari JG
    Drug Deliv; 2011 Aug; 18(6):424-31. PubMed ID: 21554152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
    Yang Z; Teng Y; Wang H; Hou H
    Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.